Oligo:Ab conjugates – an application guide

November 25th, 2013

**This webinar was produced by Innova Biosciences which is now fully integrated with their company, Expedeon Ltd., and have taken the Expedeon Ltd name and logo.   In this joint webinar oligonucleotide synthesis specialists Integrated DNA Technologies (IDT) join with bioconjugation experts Expedeon to explain the importance of using top…

View

Expedeon Ltd achieves InnovaCoat® key scale-up target

November 12th, 2013

Expedeon, the inventor of high quality, easy to use bioconjugation kits, is pleased to announce it has reached yet another significant milestone of its programme funded by the UK’s innovation agency, the Technology Strategy Board, by meeting a key scale-up target for the production of its unique InnovaCoat® gold nanoparticle conjugation reagents. Traditional passive methods…

View

Applications and advantages of alkaline phosphatase in immunoassays

September 9th, 2013

**This webinar was produced by Innova Biosciences which is now fully integrated with their company, Expedeon Ltd., and have taken the Expedeon Ltd name and logo.   There are several key benefits associated with using alkaline phosphatase (AP) as the enzyme of choice in an immunoassay. However traditional alkaline phosphatase…

View

Expedeon Develops Site-Specific Bioconjugation Technology

August 27th, 2013

Expedeon, the inventor of the world’s easiest to use antibody labeling kits, is pleased to announce the launch of a site-specific bioconjugation technology for attaching antibodies to gold nanoparticles. Innova’s core business is ‘bioconjugation’ – the joining of two molecules to form a hybrid ‘conjugate’. Conjugates are used in diagnostic tests in hospitals and research…

View

VolitionRx to use Expedeon’ Biotin Technology in its Epigenetic Research Kits

July 21st, 2013

In-licensing deal between VolitionRx and UK-based Expedeon helps drive development of novel cancer diagnostics VolitionRx Limited (OTC: VNRX), a life sciences company focused on the development of blood-based diagnostic tests, has signed a non-exclusive in-licensing agreement with Expedeon, a specialist provider of bioconjugation systems, based in Cambridge, UK. Under the agreement, Expedeon will supply its…

View

Gold nanoparticles: strange properties and applications in the Life Sciences

July 10th, 2013

**This webinar was produced by Innova Biosciences which is now fully integrated with their company, Expedeon Ltd., and have taken the Expedeon Ltd name and logo.   Gold nanoparticles exhibit extraordinary properties quite unlike those of the bulk metal. These properties can be exploited in a variety of assay applications,…

View

Lightning-Link® In-licensing Deal Enhances ImmunoReagents’ Product Offering to the Diagnostic Industry

April 29th, 2013

ImmunoReagents, the global manufacturer of high quality antibody products to the diagnostic and research industry, has entered into a non-exclusive in-licensing deal to use Expedeon (Cambridge, UK) Lightning-Link® technology for commercial purposes. Through the commercialisation deal, ImmunoReagents will utilise Innova’s technology for the manufacture of antibody conjugates, taking advantage of the very rapid Lightning Link…

View

Fluorescence Resonance Energy Transfer: a beginner’s guide

April 17th, 2013

**This webinar was produced by Innova Biosciences which is now fully integrated with our sister company, Expedeon Ltd., and have taken the Expedeon Ltd name and logo.   FRET, or Fluorescence Resonance Energy Transfer, is a powerful technique dependent on the distance dependent transfer of energy from a donor molecule…

View

Maximizing immunoassay performance with smart conjugate design

March 20th, 2013

**This webinar was produced by Innova Biosciences which is now fully integrated with our sister company, Expedeon Ltd., and have taken the Expedeon Ltd name and logo.   Labeled antibodies, also known as conjugates, are an integral component in immunoassays. As scientists push the thresholds of detection there is a…

View

Expedeon Develops Technology to Increase Sensitivity of Diagnostic Tests

February 19th, 2013

World healthcare models are continuously facing financial challenges when it comes to providing for an ageing population. The current models for provision are increasingly questioned with the upward trend in healthcare spending becoming a significant portion of the GDP. One solution to alleviate the ever increasing burden is earlier detection of disease using more accurate…

View

Drug screening assays for phosphate-generating enzymes, ATPase and GTPase assays

January 31st, 2013

**This webinar was produced by Innova Biosciences which is now fully integrated with our sister company, Expedeon Ltd., and have taken the Expedeon Ltd name and logo.   This webinar will introduce drug screening assays with a particular focus on phosphate-generating enzymes such at ATPases/GTPases. Topics covered during this twenty…

View

Expedeon is Proud to Announce Award of ISO 9001:2008 Certification

January 14th, 2013

Expedeon (Cambridge, UK) the original manufacturer and provider of high quality bioconjugation services, used primarily in research, diagnostics and the biotech industry, announced today that it has recently achieved ISO 9001:2008 certification. Expedeon has had its work processes accredited to internationally recognised quality management system (QMS) standards. In working towards this, every operational process within…

View